Sol-Gel gets go-ahead to initiate rosacea treatment studies

WashingtonThe Food and Drug Administration has acknowledged receipt of Sol-Gel’s Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea, reports Medical News Today.

source : dermatologytimes.modernmedicine.com

Related News:

• Mainstream media slants cancer articles toward unrealistically positive outcomes
• Florida Company Smart Nutra Inc. Makes Breakthough Advancement In The Treatment Of Lice
• New Surgery Without Incisions Shows Promise For Prostate Cancer Treatment
• Can We Trust What A Model Predicts?
• Biological Junk Reveals Treasure To People’s Choice Award Finalist, Australia
• iCo Therapeutics Inc. Receives Health Canada Clearance To Conduct Phase II DME Trial With iCo-007
• UB Researchers Propose A Novel Therapeutic Target For The Treatment Of Huntington’s Disease
• Do Certified Stroke Centers Deliver Speedy Treatment?
• Pool chemicals linked to disease
• Tarsa Therapeutics Advances Phase III ORACAL Trial Of Its Oral Calcitonin For The Treatment Of Postmenopausal Osteoporosis

Details :
Submited at Tuesday, December 1st, 2009 at 1:00 am on Dermatology by Gillan
Comment RSS 2.0 - leave a comment - trackback